Trombetti, Andrea
Al-Daghri, Nasser
Brandi, Maria Luisa
Cannata-Andía, Jorge B.
Cavalier, Etienne
Chandran, Manju
Chaussain, Catherine
Cipullo, Lucia
Cooper, Cyrus http://orcid.org/0000-0003-3510-0709
Haffner, Dieter http://orcid.org/0000-0002-9601-7813
Harvengt, Pol http://orcid.org/0000-0003-1283-411X
Harvey, Nicholas C. http://orcid.org/0000-0002-8194-2512
Javaid, Muhammad Kassim
Jiwa, Famida
Kanis, John A.
Laslop, Andrea
Laurent, Michaël R. http://orcid.org/0000-0001-9681-8330
Linglart, Agnès http://orcid.org/0000-0003-3455-002X
Marques, Andréa
Mindler, Gabriel T. http://orcid.org/0000-0002-8533-2164
Minisola, Salvatore http://orcid.org/0000-0001-6525-0439
Yerro, María Concepción Prieto
Rosa, Mario Miguel http://orcid.org/0000-0003-3158-2106
Seefried, Lothar http://orcid.org/0000-0003-1154-3388
Vlaskovska, Mila
Zanchetta, María Belén
Rizzoli, René http://orcid.org/0000-0002-1537-422X
Article History
Accepted: 10 March 2022
First Online: 28 April 2022
Competing interests
: A.T. has received fees for consulting from VIFOR. M.L.B. has received honoraria, consultancy and lecture fees and/or research grants from Abiogen, Alexion, Amgen, Amolyt, Bruno Farmaceutici, Calcilytix, Echolight, Eli Lilly, Kyowa Kirin, Servier, SPA, Theramex and UCB. E.C. is a consultant for DiaSorin, Fujirebio, IDS and Nittobo. C. Cooper has received lecture fees and consulting honoraria from Amgen, MSD, Eli Lilly, Procter & Gamble, Aventis, GSK/Roche, Novartis, Nycomed, Radius, Servier and Wyeth Pharmaceuticals. D.H. has received consultancy and lecture fees and/or research grants from Amgen, Chiesi and Kyowa Kirin. P.H. is an employee of GSK, but in that capacity has no financial interest in any project associated with the topic of this article. N.C.H. has received consultancy, lecture fees and honoraria from Alliance for Better Bone Health, AMGEN, MSD, Eli Lilly, Servier, UCS, Shire, Consilient Healthcare, Kyowa Kirin and Internis Pharma. M.K.J. has received grants and honoraria from Kyowa Kirin. M.R.L. has received consultancy and lecture fees from Alexion, Amgen, Kyowa Kirin, Menarini, Orifarm, Sandoz, Takeda, UCB and Will Pharma. A. Linglart has received lecture fees and/or research grants from NovoNordisk, Pfizer, Merck, Alexion and Kyowa Kirin. S.M. served as speaker for Abiogen, Amgen, Bruno Farmaceutici, Diasorin, Eli Lilly, Shire, Sandoz and Takeda, and on the advisory board of Abiogen, Kyowa Kirin, Pfizer and UCB. L.S. has received honoraria for lectures and advice from Abbvie, Amgen, Alexion, GSK, Kyowa Kirin, Eli Lilly, MSD, Novartis, Servier, Theramex and UCB, and research grants from Alexion, KyowaKirin and Novartis. M.B.Z. has received consultancy fees and lecture fees from Amgen, Eli Lilly and Ultragenyx. R.R. has received fees for lectures or advisory boards from Abiogen, Amgen, Danone, Echolight, European Milk Forum, Mithra, Nestlé, ObsEva, Pfizer Consumer Health, Radius Health, Rejunevate and Theramex. The remaining authors declare no competing interests.
Free to read: This content has been made available to all.